You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 6, 2025

Drug Price Trends for NDC 46122-0717


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 46122-0717

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

46122-0717 Market Analysis and Financial Projection

Market Analysis and Price Projections for the Drug NDC: 46122-0717

Understanding the NDC Code

The National Drug Code (NDC) is a unique 11-digit code assigned to each drug product, including the labeler code, product code, and package code. The NDC code 46122-0717 identifies a specific drug product, and understanding its components is crucial for market analysis and price projections.

Identifying the Drug Product

To analyze the market and project prices for the drug with NDC 46122-0717, it is essential to identify the drug product. This can be done using resources like the FDA's New NDC Directory, which provides detailed information on drug products, including their proprietary names, active ingredients, dosage forms, and routes of administration[1].

Market Context

The pharmaceutical market is dynamic and influenced by various factors such as regulatory changes, technological advancements, and market dynamics.

Trends in the Pharmaceutical Industry

In 2024, the pharmaceutical industry is expected to see continued dominance of small molecule drugs, increasing adoption of biologics, and a growing demand for personalized medicine. These trends can impact the pricing and market demand for specific drug products[3].

Pricing Mechanisms

Pricing for drugs, especially those covered under programs like the Medicaid Drug Rebate Program, involves complex calculations.

Medicaid Drug Rebate Program

For drugs covered under the Medicaid Drug Rebate Program, the 340B ceiling price is calculated by subtracting the Unit Rebate Amount (URA) from the Average Manufacturer Price (AMP) for the smallest unit of measure. This price is then adjusted by the package size and case pack size to determine the final ceiling price[2].

Data Sources for Price Projections

To project prices for the drug NDC 46122-0717, several data sources can be utilized:

FDA New NDC Directory

This directory provides up-to-date information on listed drugs, including their market dates, application numbers, labeler names, and package details. It is updated daily and includes data elements such as the Drug Enforcement Administration schedule and pharmacological class[1].

HRSA 340B OPAIS

The Health Resources and Services Administration (HRSA) 340B OPAIS system provides detailed product information, including the ceiling price chart, effective dates, and package-adjusted prices. This data is crucial for understanding the pricing dynamics for drugs sold to 340B covered entities[2].

Calculating Ceiling Prices

To calculate the ceiling price for the drug NDC 46122-0717, you would follow these steps:

  1. Determine the Average Manufacturer Price (AMP): This is the average price paid by wholesalers for the drug in the smallest unit of measure.
  2. Calculate the Unit Rebate Amount (URA): This is the rebate amount per unit, which varies based on the drug's classification.
  3. Adjust for Package Size and Case Pack Size: Multiply the calculated ceiling price by the package size and case pack size to get the final adjusted price[2].

Example Calculation

For illustrative purposes, let's assume the following data for the drug NDC 46122-0717:

  • AMP: $10 per unit
  • URA: $2 per unit
  • Package Size: 10 units per package
  • Case Pack Size: 5 packages per case

The ceiling price would be calculated as follows: [ \text{Ceiling Price} = (\text{AMP} - \text{URA}) \times \text{Package Size} \times \text{Case Pack Size} ] [ \text{Ceiling Price} = (10 - 2) \times 10 \times 5 = 8 \times 10 \times 5 = 400 ]

Market Dynamics and Price Projections

Market dynamics, such as changes in demand, regulatory shifts, and technological advancements, can significantly impact price projections.

Regulatory Compliance

Regulatory changes can affect pricing strategies. For instance, adjustments in the Medicaid drug rebate program can influence the best price calculations and subsequent rebates[5].

Technological Advancements

Advancements in pharmaceutical technologies, such as the use of AI in drug discovery and personalized medicine, can lead to new market opportunities and challenges. These trends may influence the pricing of drugs as companies balance innovation costs with market demand[3].

Key Takeaways

  • NDC Code Analysis: Understanding the NDC code is crucial for identifying the drug product and accessing relevant market data.
  • Pricing Mechanisms: The 340B ceiling price calculation involves subtracting the URA from the AMP and adjusting for package and case pack sizes.
  • Market Dynamics: Trends in the pharmaceutical industry, regulatory changes, and technological advancements can significantly impact price projections.
  • Data Sources: Utilize the FDA New NDC Directory and HRSA 340B OPAIS for accurate and up-to-date pricing data.

FAQs

Q: What is the National Drug Code (NDC) and how is it used? A: The NDC is a unique 11-digit code assigned to each drug product, used to identify the labeler, product, and package. It is essential for tracking and pricing drugs.

Q: How is the 340B ceiling price calculated? A: The 340B ceiling price is calculated by subtracting the Unit Rebate Amount (URA) from the Average Manufacturer Price (AMP) for the smallest unit of measure, then adjusting for package size and case pack size.

Q: What data sources are available for pricing drug products? A: Key data sources include the FDA New NDC Directory and the HRSA 340B OPAIS system.

Q: How do regulatory changes affect drug pricing? A: Regulatory changes can impact best price calculations, rebates, and overall pricing strategies, as seen in adjustments to the Medicaid drug rebate program.

Q: What role do technological advancements play in drug pricing? A: Technological advancements, such as AI in drug discovery and personalized medicine, can influence pricing by affecting innovation costs and market demand.

Sources

  1. FDA New NDC Directory - YouTube
  2. HRSA 340B OPAIS - HRSA
  3. Top 12 Pharmaceutical Industry Trends in 2024 - Global Pharma Tek
  4. Drug Reconstitution Market Size, Share, Trends, Forecast (2035) - Roots Analysis
  5. For State Medicaid Directors - Medicaid.gov

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.